Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

4.32USD
3:59pm EST
Change (% chg)

$0.10 (+2.37%)
Prev Close
$4.22
Open
$4.26
Day's High
$4.32
Day's Low
$4.00
Volume
39,005
Avg. Vol
143,792
52-wk High
$6.73
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.133
Jun '17 0.00 -0.139
Mar '17 0.00 -0.154
FY 2016 Dec '16 0.00 -0.130
Sep '16 0.00 -0.159
Jun '16 0.00 -0.201
Mar '16 0.00 -0.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 3.33 10.00 0.00 10.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.13 -0.09 -0.17 --
Quarter Ending Jun-18 2 -0.13 -0.08 -0.18 --
Year Ending Dec-18 3 -0.48 -0.35 -0.60 -0.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 192.73 34.59
P/E High - Last 5 Yrs. -- 285.47 45.93
P/E Low - Last 5 Yrs. -- 93.40 24.19
Beta 2.66 0.81 0.81
Price to Sales (TTM) -- 137.31 8.08
Price to Book (MRQ) -- 20.28 5.24
Price to Tangible Book (MRQ) 56.33 27.91 6.43
Price to Cash Flow (TTM) -- 126.48 25.98
% Owned Institutions 10.32 11.77 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.87 5.21
Payout Ratio(TTM) -- 8.18 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 65.12 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 62.55 7.61
Sales - 5 Yr. Growth Rate -- 33.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 16.42 -97.40 18.78
EPS (TTM) vs TTM 1 Yr. Ago 30.12 -- --
EPS - 5 Yr. Growth Rate -- 46.98 11.55
Capital Spending - 5 Yr. Growth Rate -- 43.68 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 1.62 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.26 12.18
Total Debt to Equity (MRQ) 0.00 18.35 15.60
Interest Coverage (TTM) -- -160.93 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.39 54.74
Gross Margin - 5 Yr. Avg. -- 55.21 52.50
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -233.45 14.67
Operating Margin (TTM) -- -490.18 4.40
Operating Margin - 5 Yr. Avg. -- -250.27 9.99
Pre-Tax Margin (TTM) -- -465.60 5.14
Pre-Tax Margin - 5 Yr. Avg. -- -256.86 10.24
Net Profit Margin (TTM) -- -447.98 1.86
Net Profit Margin - 5 Yr. Avg. -- -260.25 6.55
Effective Tax Rate (TTM) -- 0.27 21.87
Effective Tax Rate - 5 Yr. Avg. -- 17.76 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,887,942 823,803,020
Net Income/Employee (TTM) -2,634,857 -537,326 96,327,335
Receivable Turnover (TTM) -- 14.02 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.00 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -159.51 -1.02 10.76
Return on Assets - 5 Yr. Avg. -90.24 -0.09 12.05
Return on Investment (TTM) -250.97 -0.67 13.67
Return on Investment - 5 Yr. Avg. -102.11 2.39 15.78
Return on Equity (TTM) -- -3.38 15.40
Return on Equity - 5 Yr. Avg. -235.00 -1.61 17.04
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galectin Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.32%
# of Holders: 53
Total Shares Held: 3,678,033
3 Mo. Net Change: -153,142
# New Positions: 8
# Closed Positions: 7
# Increased Positions: 16
# Reduced Positions: 22
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.